Navigation Links
Germany Prioritizes Medical Biotechnology with New Initiatives
Date:9/17/2012

BERLIN and BOSTON, September 17, 2012 /PRNewswire/ --

The new round of funding by Germany's Ministry of Education and Research will provide EUR 40 million for biotechnology research. At the same time, the Health - Made in Germany initiative has been set up to turn Germany into a business hub for the international healthcare industry. With these new initiatives, Germany is consolidating its position as Europe's top medical biotechnology location.

"We are hosting a breakfast seminar on September 18 in Boston to bring together important players from the German and American biotechnology sectors. One of Germany's top clusters, BioM Munich and Massachusetts association MassBio will have a chance to highlight bilateral ties. This meeting will be a great start to this year's BioPharm America 2012, happening from September 19-21 in Boston," stated Sandra Buetow, pharmaceutical industry expert for Germany Trade & Invest in Berlin.

Germany features over 500 dedicated biotechnology companies. Nearly half of these companies develop new drugs or diagnostic methods in the areas of human and animal medicine, making this one of the most important applications of biotechnology. The United States is the top investor in Germany, according to Germany Trade & Invest statistics. At the same time, the USA is an essential market for German exports.

Health - Made in Germany is an initiative to create win-win situations for global partners and German healthcare companies. Supported by the Federal Ministry of Economics and Technology and carried out by Germany Trade & Invest, the initiative allows companies, federal clusters, and professional associations to benefit from business opportunities in the healthcare field.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities in the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

Germany Trade & Invest
Andreas Bilfinger
Email: andreas.bilfinger@gtai.com
T: +49(0)30-200099-173
http://www.gtai.com/press-subscription
http://twitter.com/gtai_com
http://youtube.com/gtai


'/>"/>
SOURCE Germany Trade and Invest
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
2. World record: Scientists from northern Germany produce the lightest material in the world
3. Marken Opens Two Pharmaceutical Depots In New York & Germany
4. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
5. DiaTech Life Sciences Announces Medical Advisory Board
6. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
7. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
8. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
9. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
10. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
11. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... & Investor Conference 2016, to be held February 8-9, ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, taking ... February 10-11, 2016. James Sapirstein , Chief ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... supplier of Semantic Graph Database technology has been recognized As “ Best in ... Corporate America Magazine. , “At Corporate America, it’s our priority to showcase prominent ...
(Date:2/3/2016)...   ViaCyte, Inc ., a leading, privately-held ... cell-derived islet replacement therapy for the treatment of ... that ViaCyte and Janssen Biotech, Inc., one of ... have agreed to consolidate the assets of the ... ViaCyte with an exclusive license to all BetaLogics ...
(Date:2/3/2016)... , Feb. 3, 2016 Ascendis Pharma ... company that applies its innovative TransCon technology to address ... at an upcoming investor conference.Event:2016 Leerink Partners Global Healthcare ... Date:  , Wednesday, February 10, 2016 Time:  , ... www.ascendispharma.com . --> An audio webcast of ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/13/2016)... New York , January 13, 2016 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2023. According to the ... in 2014 and is anticipated to reach US$1,625.8 mn ... 2015 to 2023. In terms of volume, the biometric ...
(Date:1/11/2016)... , Jan. 11, 2016  higi, the leading ... 10,000 retail locations, web and mobile, today announced ... million from existing investors. --> ... devoted to further innovate higi,s health platform – ... web portal – including expanding services and programs ...
Breaking Biology News(10 mins):